Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday 3 July 2019

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $RIV.V) (TSX: $TRST.TO) (TSXV: $WL.V)


Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $RIV.V) (TSX: $TRST.TO) (TSXV: $WL.V)

Also featured in today’s potcast – (TSXV: $HVT.V) (CSE: $HITI.C) (TSXV: $META.V) (TSXV: $FAF.V)



Delta, Kelowna, BC –July 3, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at a few early announcements.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Bruce Linton announced that Bruce will step down as co-CEO and Canopy Board member. Mark Zekulin has agreed to become the sole CEO of the company and will work with the Board to begin a search to identify a new leader to guide the company in its next phase of growth, which will include both internal and external candidates. Rade Kovacevic, a long-serving member of the team currently leading all Canadian operations and recreational strategy will assume the role of President. These changes are effective immediately.
                             
"Creating Canopy Growth began with an abandoned chocolate factory and a vision," said Linton. "The Board decided today, and I agreed, my turn is over. Mark has been my partner since this Company began and has played an integral role in Canopy's success. While change is never easy, I have full confidence in the team at Canopy – from Mark and Rade's leadership to the full suite of leadership – as we progress through this transition and into the future."        
         
"We thank Bruce and Mark for establishing the foundation for a company that is very well-positioned to lead in the emerging global cannabis market," said Canopy Growth board director, David Klein. "We are also excited to embark upon our next phase of growth as global leader in the cannabis industry."
                             
Canopy Growth has experienced rapid growth since being founded in 2013, establishing leading positions in Canada's medical and recreational cannabis markets and building an emerging presence in a number of additional markets around the world. The company recently received a $5 billion (CAD) investment from Constellation Brands, a leading beverage alcohol company, which provides a significant benefit as Canopy continues to establish a first-mover advantage in the quickly evolving global cannabis market.

"While Canopy will never be the same without Bruce, the team and I look forward to continuing to do what we have done for the past 6 years: investing in world class people, infrastructure and brands, and always seeking to lead through credibility and vision," said Zekulin. "I personally remain committed to a successful transition over the coming year as we begin a process to identify new leadership that will drive our collective vision forward. I know the company will continue to thrive as the Canopy story continues on for years to come." 

The Board has also appointed John Bell as its Board Chair, to be reviewed at the Board's annual meeting in September when new board members are elected. Bell has served on the board as lead director for 5 years.

Further to Canopy Growth Corporation's press release today, Bruce Linton has also stepped down as Chairman and Director of Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF), effective immediately. Canopy Rivers' board of directors and executive team would like to thank Mr. Linton for his contributions to the Company through the early development of the global cannabis sector.

"We are grateful for all of the contributions that Bruce made to both Canopy Rivers and to the cannabis industry as a whole," said Narbe Alexandrian, President and CEO of Canopy Rivers. "As we enter the next chapter of our Company's history, we are excited to continue working with Canopy Growth."

CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) announced an update on its outdoor cultivation operations in British Columbia and its first shipment of capsule and dry flower products to Australia.

After closing the purchase of its first 81 acres of land in British Columbia for outdoor cannabis cultivation, CannTrust immediately invested in fencing, security, irrigation and other land preparation activities and applied for Health Canada approval to plant and cultivate on the land. Based on its estimate of yields and projected date of permitting at the time, CannTrust estimated 75,000kg of cannabis could be produced from this property in 2019. As CannTrust has yet to receive its Health Canada permit at this stage of the growing season, it is now estimated that production from this operation could range from 0 to 15,000kg in 2019, subject to the timing and receipt of regulatory approvals. A crop of up to 15,000kg is expected if planting is completed in the first half of July 2019 and yields will diminish if a crop is planted in the second half of the month. If a crop is not planted by August 5, 2019, there will be no outdoor harvest in 2019.

CannTrust expects to reach a definitive agreement for a long-term lease for an additional 160 acres in the near term and that all properties, representing over 240 acres of land, will be prepared for planting at the beginning of the growing season in 2020. Between these two properties, CannTrust continues to expect that it can produce between 100,000kg to 200,000kg of cannabis in British Columbia in 2020, subject to regulatory approvals.

"We have access to premium land in a very rich agricultural region and we remain undeterred in our long-term strategy to develop innovative cannabis products at low cost," said Peter Aceto, Chief Executive Officer.

Last week, CannTrust completed its first shipment of CBD, THC and 1:1 CBD:THC vegan capsules and dry flower products to Australia. These products will be resold by its partner Cannatrek Ltd. to medical patients in Australia. These shipments are expected to continue until Cannatrek's operations achieve commercial production. CannTrust now has nine products available to medical patients in Australia.

"The first steps to build CannTrust's global footprint were established last year through partnerships in Europe and Australia.  We continue to make excellent progress with our partners in these regions as they build their operations and through our regular shipments of our award-winning products to both Denmark and Australia. We will continue taking action to establish leading positions in medical cannabis markets around the world. CannTrust is in an excellent position to increase our international business as medical and recreational cannabis continue to gain acceptance worldwide," said Peter Aceto.

Westleaf Inc. (TSX-V:WL) (OTCQB:WSLFF) announced the completion of construction on its wholly owned cannabis extraction, processing and product formulation facility, The Plant by Westleaf Labs, which will have a throughput capacity of up to 65,000 kilograms per annum in Phase I. The facility is now entering the final stages of the Health Canada licensing process. The Company expects to receive a Standard Processing license for The Plant as early as Q3 2019 and anticipates that production at the facility would commence shortly thereafter. This marks a major operational milestone for Westleaf and, once licensed, will allow the Company to produce its own branded cannabis products, as well as provide contract manufacturing and white-label opportunities to other cannabis companies.

"This is a significant milestone for Westleaf, marking our transition from construction to operations and execution on our plan to build a brand focused vertically integrated cannabis company," said Scott Hurd, President and CEO. "Once licensed, this facility will produce the current suite of legal cannabis derivative products, and as we move towards additional cannabis product legalization in the fourth quarter, we will expand our product lines to include vapes, edibles and other derivative cannabis products."

As a result of Westleaf Inc.'s unique brand focused vertically-integrated business model, it is expected that The Plant will give the Company a competitive advantage in being adaptive to consumer needs and interests. "The Plant will also allow us to be flexible and responsive to consumer demand and underscores the value of the Westleaf business model," said Adam Coates, Chief Commercial Officer at Westleaf. "By owning the customer experience and feedback loop through our Prairie Records cannabis stores, we can alter production based on the trends of our customers."

Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) and Delivra Corp. (TSXV: DVA) announced today that they have completed the previously announced plan of arrangement under the provisions of the Business Corporations Act (Ontario), pursuant to which Harvest One acquired all of the issued and outstanding common shares of Delivra.

"We are delighted to close this transaction and welcome Delivra to the Harvest One team" said Grant Froese, Chief Executive Officer of Harvest One. "The addition of the LivRelief™ brand to our existing product portfolio emphasizes our goal of becoming a global leader in the health, wellness, and self-care sector. There are significant synergies between both organizations and we expect an expeditious integration. We will look to expand the development of Delivra's products globally with an expanded reach of the current formulation and new products, including cannabinoid infused products, when and where legal."
  
Dr. Joseph Gabriele, Director, Chief Executive Officer, and Chief Scientific Officer of Delivra, added, "Harvest One's health and wellness strategy coupled with their expanding distribution capabilities will ensure that our LivRelief™ product will reach more people in Canada and beyond. Delivra shareholders showed overwhelming support for this transaction and we look forward to the next stage of our development as part of the Harvest One team as we extend our reach, our offerings, and capitalize on markets where CBD infused products are legal."

Concurrent with the completion of the Arrangement, Dr. Joseph Gabriele, the current CEO of Delivra, joined the Board of Directors of Harvest One. With the exception of Dr. Joseph Gabriele, each of the directors of Delivra resigned from the Board of Directors of Delivra.

High Tide Inc. (CSE:HITI) (OTCQB:HITIF) today announced that the Canna Cabana retail store located at 10831 100 Street in Grande Prairie, Alberta received its first delivery of cannabis products from Alberta Gaming, Liquor and Cannabis and began selling recreational cannabis for adult use on June 29, 2019. The Grande Prairie Store had been selling smoking accessories since late January but was licensed by AGLC as High Tide's fifth retail cannabis store on June 3, 2019.

Barring any changes to the rate of licensing recently accelerated by AGLC, High Tide expects its next 10 Canna Cabana stores to begin retailing cannabis over the next 8 weeks. "With even faster licensing by AGLC, we are excited to continue our rapid growth to becoming Canada's leading cannabis retailer," said Raj Grover, President and Chief Executive Officer of High Tide. "Maximizing the Canna Cabana retail experience in Alberta as Canada's leading retail cannabis jurisdiction is a great opportunity for our customers, stakeholders and shareholders alike," added Mr. Grover. The Company expects these next ten Canna Cabana stores, including one franchise, to be licensed as retail cannabis stores throughout the summer, which will bring its total number of retail cannabis stores to 15 branded locations across Alberta.

The remaining 22 locations to reach the effective maximum of 37 retail cannabis stores in Alberta are currently under various stages of development and construction. Outside of Alberta, High Tide currently has a Canna Cabana retail cannabis store in Swift Current, Saskatchewan, along with three branded locations in Hamilton, Sudbury and Toronto, Ontario. High Tide is also progressing toward closing the previously announced acquisition of a second location in Saskatchewan, establishing a retail cannabis store in Niverville, Manitoba after winning the opportunity to do so by provincial draw in May and opening the maximum number of eight locations in British Columbia.

National Access Cannabis Corp. (TSXV: META), today announced it has received two additional licences from the Alberta Gaming, Liquor and Cannabis Commission to open cannabis retail stores in Alberta. The retail stores will be located in the cities of Calgary and Airdrie. The announcement comes following the previously released news that the AGLC has lifted the moratorium on new cannabis retail licences.

"We continue our rapid growth in Alberta," said Mark Goliger, CEO of NAC. "With two new licences quickly following the three new licences announced on June 18th, we continue to expand our private cannabis retailing footprint in Alberta and across Canada."
NAC currently operates in three provinces, has applied for licences in British Columbia and plans to make applications for licences in Ontario once licensing opens up to more private retailers. NAC's experienced team of retail industry professionals is focused on achieving its business plan of having 40 operating stores by the end of calendar 2019, and 110 operating stores by the end of calendar 2020.  
Fire & Flower Holdings Corp. and its wholly-owned subsidiary Fire & Flower Inc. (TSXV: FAF), today announced that it has received an additional licence to operate a cannabis retail store in Lethbridge, Alberta from the Alberta Gaming, Liquor and Cannabis Comission.

Once opened, this store will be the 22nd Fire & Flower branded, licensed cannabis store and will be located at 2424 Fairways Plaza Road South in Lethbridge, Alberta. This announcement of an additional Alberta licensed cannabis store demonstrates Fire & Flower's commitment to its near-term rollout schedule. The Lethbridge location has been built out and is ready for opening once final inspections occur and cannabis products are received.

"The rapid rate at which the AGLC is issuing cannabis retail licenses demonstrates Alberta is open for business and this province is a leader in cannabis retail," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "Our recent bought deal private placement financing of $27,000,000 ensures Fire & Flower is well positioned to capitalize on the accelerated store licensing."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411



  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories




Tuesday 2 July 2019

Investorideas.com - Organic Farming Guru Phil Coturri To address Sonoma Valley Cannabis Enthusiasts

Investorideas.com - Organic Farming Guru Phil Coturri To address Sonoma Valley Cannabis Enthusiasts

Investorideas.com - Cannex (CSE: CNNX; OTCQX: CNXXF) secures licensing and infrastructure to support major strategic California expansion

Investorideas.com - Cannex (CSE: CNNX; OTCQX: CNXXF) secures licensing and infrastructure to support major strategic California expansion

Investorideas.com - Cannabis Stock News: KushCo Holdings (OTCQX:$KSHB) Partners with C.A. Fortune to Expand Retail Opportunities for CBD Brands

Investorideas.com - Cannabis Stock News: KushCo Holdings (OTCQX:$KSHB) Partners with C.A. Fortune to Expand Retail Opportunities for CBD Brands

Investorideas.com - Indus Holdings, Inc. (CSE:INDS) Honored At Monterey County Business Council Economic Vitality Awards Gala

Investorideas.com - Indus Holdings, Inc. (CSE:INDS) Honored At Monterey County Business Council Economic Vitality Awards Gala

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $KHRN.V) (OTCQB: $KHRNF), (CSE: $MYM.C) (OTCBB: $MYMMF) (NASDAQ: $OGI)


Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $KHRN.V) (OTCQB: $KHRNF), (CSE: $MYM.C) (OTCBB: $MYMMF) (NASDAQ: $OGI)

Also featured in today’s potcast- (CSE: $HUGE.C) (OTCQB: $FSDDF) (TSXV: $OGI.V), (TSX: $IN.TO) (OTCQX: $IMLFF)



Delta, Kelowna, BC –July 2, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at a few early announcements.

But first, Health Minister Simon Harris signed legislation which will now allow Irish citizens access to cannabis-based products for medical use on a pilot basis for five years. The new Medical Cannabis Access Programme  allows medical consultants to prescribe medicinal cannabis of a standardised quality to patients who have failed to respond to standard treatments.

Minister Harris first proposed the programme two years ago, but its passage through the Dáil was delayed amid problems finding a quality-assured supplier of medicinal cannabis able to export its products to Ireland.
Earlier this year, it was confirmed that a supplier had been identified and the legislation was finally signed this morning.
The new scheme will facilitate access to medical cannabis for patients with the following conditions if they have failed to respond to standard treatments:
      Spasticity associated with multiple sclerosis
      Intractable nausea and vomiting associated with chemotherapy
      Severe, refractory (treatment-resistant) epilepsy
Commenting on the launch today, Mr Harris said: "It is important to state that there are no plans to legalise cannabis in this country.
"The purpose of this programme is to facilitate compassionate access to cannabis for medical reasons, where conventional treatment has failed.
"Ultimately it will be the decision of the medical consultant, in consultation with their patient, to prescribe a particular treatment, including a cannabis-based treatment, for a patient under their care."
Previously, there were no medical cannabis products available in Ireland and many sufferers were forced to spend thousands each year to access cannabis-based treatments in countries such as the Netherlands.
The new legislation means that commercial operators whose cannabis products meet the specified requirements will be able to supply products to the Irish market.
The Medical Cannabis Access Programme will operate on a pilot basis for five years before a review in 2024.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), commented on the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina, Brazil, Uruguay and Paraguay. Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay.

The trade deal between the European Union and Mercosur announced on June 28, 2019 at the G20 Summit in Japan, which is subject to ratification by member countries, establishes a trade framework for goods and services, including pharma and medical products, covering nearly 780 million consumers, making it the largest in the world in terms of population, and with an estimated trade in goods of 88 Billion Euros (Source: European Commission).

Alvaro Torres, Khiron CEO and Director, comments "As we build Khiron's dominant position in Latin America and Mercosur markets through our operations in Uruguay, we welcome this trade deal as it strengthens our ability to now directly supply the European medical cannabis market. This significant milestone is another step towards a globalized medical cannabis trade network where Latin America, with its strategic location, many natural advantages and regulatory leadership, will continue to play a significant part."

Khiron announced completion of the acquisition of NettaGrowth International on June 19, 2019. NettaGrowth, and its wholly-owned subsidiary Dormul S.A. is a Uruguayan company that has obtained one of the first licences to produce and export medical cannabis with THC for commercialization in Uruguay, and is positioned to serve Brazil and the growing Latin American market as part of the Mercosur trading block, adopting the Company's scalable model as markets develop.

MYM Nutraceuticals Inc. (CSE: MYM) (OTCBB: MYMMF) announced that its subsidiary in Colombia, Colombia Organica S.A.S, has signed agreements in principle to cultivate both THC and CBD-rich cannabis with independent farmers for an initial five acres.

Cannabis will be cultivated by farmers who will be licensees under the existing Colombia Organica cannabis cultivation licenses. The first crops cultivated on the initial five acres will function as test crops with the intention to add subsequent acreage. The climate in Colombia is ideal for cultivating cannabis, with the growing season being year-round it's possible to harvest three crops of THC or CBD-rich cannabis annually.

"Our team in Colombia has begun to execute on our plan to cultivate both THC and CBD-rich cannabis in South America," said Howard Steinberg, CEO of MYM. "The strategy of extending our licenses to neighbouring farmers to cultivate cannabis will serve to increase our biomass supply that we intend on processing and exporting to the global market."

Colombia Organica is committed to extending its licenses to the independent farmers for an initial period of five years. The farmers will be responsible for all costs associated with cultivation from seed to sale. Colombia Organica agrees to purchase the harvested biomass at a price to be determined at the time of delivery based on the average market price at that time.

MYM is currently finalizing the closing documents that will see its own 80% of Colombia Organica.

Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open. 

The Company will host a conference call to discuss its third quarter 2019 earnings results at 8am EST.

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.


FSD Pharma Inc. (CSE:HUGE) (OTCQB: FSDDF) and Prismic Pharmaceuticals Inc., a U.S.-based specialty R&D pharmaceutical company, have announced that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic for an aggregate purchase price of approximately US$17.5 million, satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma at a deemed price of CAD$0.2275 per FSD Share. In addition, FSD Pharma has agreed to assume approximately US$3.05 million of outstanding Prismic long- and short-term liabilities.

FSD Pharma will continue to be led by Raza Bokhari, MD, executive co-chairman and CEO. Zachary Dutton, co-founder of Prismic, will continue to serve as the CEO of Prismic, reporting to Edward Brennan, Jr. MD, FACS, president of the FSD Biosciences Division.

Peter Moriarty, co-founder and previous chairman of the board of Prismic, has been named chairman of the newly-formed FSD BioPharmaceutical Industry Advisory Board.

Bokhari stated, “On behalf of the FSD Pharma shareholders and Board of Directors, it is with immense pleasure that I welcome Prismic shareholders and stakeholders to the FSD Pharma family. Over the past several weeks, Dr. Brennan and our M&A team have worked very closely with the Prismic leadership to finalize this transaction under budget and ahead of schedule. I must commend Dr. Brennan on his laser sharp focus and attention to detail and I must also express my special gratitude to Zach Dutton and Peter Moriarty for their efforts in resolving some outstanding issues to close the transaction.”

Bokhari continued, “The Prismic acquisition represents strategic depth in the vision and mission of FSD Pharma and signals a paradigm shift in the overall outlook of the company. We are relying heavily on the expertise of Dr. Brennan, who is a seasoned pharmaceutical industry veteran with substantial experience from working at Glaxo Smith Kline and Johnson & Johnson to navigate us through the various stages of the FDA approval process for drug development, with the goal of eventually making synthetic cannabinoid prescription medications available for commercial use to help alleviate the pain and suffering of patients. We are confident, Peter Moriarty, another well-known pharmaceutical industry veteran, who was also one of the founders of Shire Pharmaceuticals, will make a meaningful contribution to the FSD Pharma story as the chairman of the BioPharmaceutical industry advisory board.”

InMed Pharmaceuticals Inc. (TSX:IN) (OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis technology for cannabinoid-based pharmaceuticals to treat severe diseases, today announced the appointment of Catherine Sazdanoff, JD, to its Board of Directors.

Ms. Sazdanoff joins InMed's Board with 35 years of experience in the healthcare industry. She held various global VP roles in business development and corporate development at Takeda Pharmaceuticals, which she joined in 2006. Prior to Takeda, Ms. Sazdanoff served in senior global legal and pharmaceutical business roles at Abbott Laboratories since 1984, including litigation, international commercial and transactional legal roles, marketing, and business development. At both companies, she completed numerous collaborations and transformational M&A transactions, including Abbott's acquisition of Knoll Laboratories (including the mega-blockbuster drug Humira®), and Takeda's acquisition of Millennium Pharmaceuticals and Nycomed S.A.

Ms. Sazdanoff is an independent director of the Board of Meridian Bioscience, Inc. (NASDAQ: VIVO). She is currently President and CEO of Sazdanoff Consulting LLC, where she acts as Business Advisor to Strata Oncology, Inc., a private precision oncology company, and works with other healthcare companies on strategy and corporate/business development. Ms. Sazdanoff has a BA in English from the University of Notre Dame, and a JD from Northwestern University School of Law.

"We are enthusiastic to welcome Catherine to our Board of Directors at an exciting time in the Company's evolution," commented Eric A. Adams, President and Chief Executive Officer. "Her diverse business development and legal experience, built from over 35 years in the pharmaceutical industry, will be important as we accelerate the development of our therapeutic pipeline and scale-up our innovative biosynthesis platform technology. Importantly, Catherine's rich experience in pharma deal making will be highly beneficial to InMed as our assets mature and we begin strategizing about potential transactions."
"InMed has unique opportunities to bring significant medical advances to important patient populations with its differentiated cannabinoid-based therapeutic pipeline and novel biosynthesis manufacturing technology," stated Ms. Sazdanoff. "I am delighted to join the team and look forward to working closely with the Company's management as InMed drives towards long-term value creation."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories


Investorideas.com - The Acquisition Flurry In Cannabis and CBD Continue (OTC: $SIML) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $CRFT.C) (CSE: $IAN.C) (OTCQX: $ITHUF)

Investorideas.com - The Acquisition Flurry In Cannabis and CBD Continue (OTC: $SIML) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $CRFT.C) (CSE: $IAN.C) (OTCQX: $ITHUF)

Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">

Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX...